An Open-Label, Randomized, Crossover Study to Assess the Bioavailability of Dexpramipexole Administered in Soft Food and Water, and in Intact Tablet Form in the Fasted and Fed States in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 17 Dec 2014
At a glance
- Drugs Dexpramipexole (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Pharmacokinetics
- Sponsors Knopp Biosciences
- 16 Aug 2012 Actual initiation date (Jun 2012) added as reported by ClinicalTrials.gov.
- 16 Aug 2012 Actual end date (July 2012) added as reported by ClinicalTrials.gov.
- 01 Jul 2012 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.